Zelira Therapeutics Limited (FRA:G1G)

Zelira Therapeutics Revenue

In the fiscal year ending June 30, 2025, Zelira Therapeutics had annual revenue of 656.00 AUD, down -99.31%. Zelira Therapeutics had revenue of 1.00 in the half year ending June 30, 2025, a decrease of -100.00%.

• Revenue: 656.00 AUD
• Revenue Growth: -99.31%
• P/S Ratio: 6,319.93
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.31M EUR

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	656.00	-94.30K	-99.31%
Jun 30, 2024	94.95K	-206.17K	-68.47%
Jun 30, 2023	301.12K	-1.24M	-80.45%
Jun 30, 2022	1.54M	877.31K	132.26%
Jun 30, 2021	663.32K	-	-